关注
Sharlene Gill
Sharlene Gill
Professor of Medicine
在 bccancer.bc.ca 的电子邮件经过验证
标题
引用次数
引用次数
年份
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?
S Gill, CL Loprinzi, DJ Sargent, SD Thomé, SR Alberts, DG Haller, ...
Journal of clinical oncology 22 (10), 1797-1806, 2004
13242004
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
E Van Cutsem, WL Vervenne, J Bennouna, Y Humblet, S Gill, ...
Journal of clinical oncology 27 (13), 2231-2237, 2009
7982009
Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial
SR Alberts, DJ Sargent, S Nair, MR Mahoney, M Mooney, SN Thibodeau, ...
Jama 307 (13), 1383-1393, 2012
5932012
A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors
AM Scott, FT Lee, N Tebbutt, R Herbertson, SS Gill, Z Liu, E Skrinos, ...
Proceedings of the National Academy of Sciences 104 (10), 4071-4076, 2007
3062007
Role of cyclooxygenase-2 in colorectal cancer
FA Sinicrope, S Gill
Cancer and Metastasis Reviews 23, 63-75, 2004
2992004
PANCREOX: a randomized phase III study of fluorouracil/leucovorin with or without oxaliplatin for second-line advanced pancreatic cancer in patients who have received …
S Gill, YJ Ko, C Cripps, A Beaudoin, S Dhesy-Thind, M Zulfiqar, ...
Journal of Clinical Oncology 34 (32), 3914-3920, 2016
2802016
The colon health and life-long exercise change trial: a randomized trial of the National Cancer Institute of Canada Clinical Trials Group
KS Courneya, CM Booth, S Gill, P O’Brien, J Vardy, CM Friedenreich, ...
Current oncology 15 (6), 271, 2008
2042008
The Chennai Declaration: a roadmap to tackle the challenge of antimicrobial resistance
A Ghafur, D Mathai, A Muruganathan, JA Jayalal, R Kant, D Chaudhary, ...
Indian Journal of Cancer 50 (1), 71-73, 2013
1802013
Adjuvant chemotherapy use and outcomes of patients with high‐risk versus low‐risk stage II colon cancer
A Kumar, HF Kennecke, DJ Renouf, HJ Lim, S Gill, R Woods, C Speers, ...
Cancer 121 (4), 527-534, 2015
1642015
Asian ethnicity–related differences in gastric cancer presentation and outcome among patients treated at a Canadian Cancer Center
S Gill, A Shah, N Le, EF Cook, EM Yoshida
Journal of clinical oncology 21 (11), 2070-2076, 2003
1552003
Adjuvant therapy for stage II colon cancer: ASCO guideline update
NN Baxter, EB Kennedy, E Bergsland, J Berlin, TJ George, S Gill, PJ Gold, ...
Journal of Clinical Oncology 40 (8), 892-910, 2022
1502022
Napabucasin versus placebo in refractory advanced colorectal cancer: a randomised phase 3 trial
DJ Jonker, L Nott, T Yoshino, S Gill, J Shapiro, A Ohtsu, J Zalcberg, ...
The lancet Gastroenterology & hepatology 3 (4), 263-270, 2018
1492018
NRG1 Gene Fusions Are Recurrent, Clinically Actionable Gene Rearrangements in KRAS Wild-Type Pancreatic Ductal Adenocarcinoma
MR Jones, LM Williamson, JT Topham, MKC Lee, A Goytain, J Ho, ...
Clinical Cancer Research 25 (15), 4674-4681, 2019
1472019
Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis
GK Gresham, GA Wells, S Gill, C Cameron, DJ Jonker
BMC cancer 14, 1-13, 2014
1432014
Phase 2 trial of linifanib (ABT‐869) in patients with unresectable or metastatic hepatocellular carcinoma
HC Toh, PJ Chen, BI Carr, JJ Knox, S Gill, P Ansell, EM McKeegan, ...
Cancer 119 (2), 380-387, 2013
1402013
Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review
K Saad El Din, JM Loree, EC Sayre, S Gill, CJ Brown, H Dau, MA De Vera
Bmc Cancer 20, 1-14, 2020
1362020
Adjuvant mFOLFOX6 with or without cetuxiumab (Cmab) in KRAS wild-type (WT) patients (pts) with resected stage III colon cancer (CC): Results from NCCTG Intergroup Phase III …
SR Alberts, DJ Sargent, TC Smyrk, AF Shields, E Chan, RM Goldberg, ...
Journal of Clinical Oncology 28 (18_suppl), CRA3507-CRA3507, 2010
1332010
Obstacles to residents' conducting research and predictors of publication
S Gill, A Levin, O Djurdjev, EM Yoshida
Academic Medicine 76 (5), 477, 2001
1222001
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study
SR Alberts, NR Foster, RF Morton, J Kugler, P Schaefer, M Wiesenfeld, ...
Annals of Oncology 16 (10), 1654-1661, 2005
1192005
Colorectal cancer chemotherapy
S Gill, RR Thomas, RM Goldberg
Alimentary pharmacology & therapeutics 18 (7), 683-692, 2003
1182003
系统目前无法执行此操作,请稍后再试。
文章 1–20